Skip Nav Destination
Issue Archive
December 2025
In Progress
Volume 1 Issue 3 | Blood Immunology & Cellular Therapy | American Society of Hematology
NONCELLULAR IMMUNOTHERAPY
Low-dose nivolumab and lenalidomide in relapsed/refractory Hodgkin lymphoma: a single-arm phase 2 trial
Anu Korula,Uday Kulkarni,Arun Kumar Arunachalam,Phaneendra Datari,Aswin Anand Pai,Sumith Mathew,Fouzia Nambiatheyil Aboobacker,Sushil Selvarajan,Sharon Lionel,Kavitha Lakshmi,Aby Abraham,Biju George,Poonkuzhali Balasubramanian,Vikram Mathews
GENE THERAPY
Cellular Immunotherapy
Donor lymphocyte infusions after HCT are associated with low risk of graft-versus-host disease in pediatric and young adult patients
Shruthi Suryaprakash,Yilun Sun,Dinesh Keerthi,Amr Qudeimat,Ali Suliman,Aimee C. Talleur,Esther Obeng,Ewelina Mamcarz,Renee Madden,Rebecca Epperly,Senthil V. Bhoopalan,Swati Naik,Caitlin C. Zebley,M. Paulina Velasquez,Paula Arnold,Li Tang,Stephen Gottschalk,Brandon M. Triplett,Akshay Sharma
Viral vector-free generation of orthogonal IL-2–responsive CAR T cells through gene editing of IL-2 and its receptor
Qian Zhang,Yihao Wu,Jingyi Yang,Kevin Zhou,Eric Nigel Ebenezer Anand Manoharan,Tyra Wentz,Leon Su,Alvin Yu,Hong-Yi Wang,Laurakay Bruhn,Israel Steinfeld,Nicolas Gonzalez,Edward Z. Song,Yunlin Zhang,Morgan E. Hresko,Daniel E. Ryan,Nils W. Engel,Selene Nunez-Cruz,Carl H. June,K. Christopher Garcia,Michael C. Milone
IMMUNOBIOLOGY
Advertisement intended for health care professionals
Advertisement intended for health care professionals









